- Stephens Annual
Investment Conference | NASH2021- Conference dates:
December 1 - 3, 2021 - Presentation details: Recro management will participate in a fireside chat on
Friday, December 3, 2021 at 11:00 –11:45am CT /12:00 –12:45pm ET . The company will also host 1-on-1 meetings with investors onFriday, December 3, 2021 - Location:
Omni Nashville Hotel ,Nashville, TN - Webcast: A live audio webcast of the fireside chat will be available under "Events" in the Investors section of the company's website, https://ir.recropharma.com/events. An archived webcast will be available on the company's website approximately two hours after the event and will be available for 30 days.
- Conference dates:
About Recro
Recro (NASD: REPH) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.
In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Recro has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in
For more information about Recro’s CDMO solutions, visit recrocdmo.com.
ContactsStephanie Diaz (Investors)Vida Strategic Partners (415) 675-7401 sdiaz@vidasp.comTim Brons (Media)Vida Strategic Partners (415) 675-7402 tbrons@vidasp.comRyan D. Lake (CFO) Recro (770) 531-8365 ryan.lake@recroCDMO.com
Source:
2021 GlobeNewswire, Inc., source